Viewing Study NCT00911560


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-03-09 @ 8:18 AM
Study NCT ID: NCT00911560
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-05
First Post: 2009-05-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma
Sponsor:
Organization: